Science Explorer Back to mapMap

Most cited papers in Intraperitoneal and Appendiceal Malignancies

Intraperitoneal and Appendiceal Malignancies

What are the most cited papers in Intraperitoneal and Appendiceal Malignancies?

The most cited paper in Intraperitoneal and Appendiceal Malignancies is "Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature" (Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al., 2015), with 5,277 citations. Next come "Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer" (3,738) and "Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer" (2,878).

Showing 50 of 100 papers. Every paper with more than 602 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology Open access 3 Nov 2015 5,277
2 Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer Yuman Fong, Joseph G. Fortner, Ruth L. Sun et al. · Annals of Surgery Open access Sep 1999 3,738
3 Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer William Patrick McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine Open access 4 Jan 1996 2,878
4 A 5‐decade analysis of 13,715 carcinoid tumors Irvin Mark Modlin, Kevin D. Lye, Mark S. Kidd · Cancer 3 Feb 2003 2,758
5 Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Herbert Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine Open access 27 Aug 2003 2,691
6 Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer Deborah Kay Armstrong, Brian N. Bundy, Lari B. Wenzel et al. · New England Journal of Medicine Open access 4 Jan 2006 2,644
7 Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis Robert E. Bristow, Rafael S. Tomacruz, Deborah Kay Armstrong et al. · Journal of Clinical Oncology Review Mar 2002 2,342
8 A Phase 3 Trial of Bevacizumab in Ovarian Cancer Timothy John Perren et al. · New England Journal of Medicine Open access 28 Dec 2011 2,183
9 Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology 15 Jul 2003 2,065
10 Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Victor J. Verwaal, Serge van Ruth, Eelco de Bree et al. · Journal of Clinical Oncology 10 Oct 2003 2,050
11 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Bernard Nordlinger, Halfdan Sørbye, Bengt L. G. Glimelius et al. · The Lancet Open access Mar 2008 1,952
12 Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases Eddie K. Abdalla, Jean‐Nicolas Vauthey, Lee M. Ellis et al. · Annals of Surgery Open access 17 May 2004 1,758
13 Peritonectomy Procedures Paul Hendrick Sugarbaker · Annals of Surgery Open access 1995 1,554
14 Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results Gooitzen M. van Dam, George Themelis, Lucia M. A. Crane et al. · Nature Medicine 18 Sep 2011 1,544
15 Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy René A. Adam, Valerie Delvart, Gérard Pascal et al. · Annals of Surgery Open access 21 Sep 2004 1,481
16 Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines Salomone Di Saverio et al. · World Journal of Emergency Surgery Open access 15 Apr 2020 1,456
17 Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Willemien J. van Driel, Simone N. Koole, Karolina Sikorska et al. · New England Journal of Medicine Open access 17 Jan 2018 1,440
18 OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Carol A Aghajanian, Stephanie V. Blank, Barbara Ann Goff et al. · Journal of Clinical Oncology Open access 24 Apr 2012 1,386
19 Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Bernard Nordlinger, Halfdan Sørbye, Bengt L. G. Glimelius et al. · The Lancet Oncology 10 Oct 2013 1,336
20 Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management Aneel Bhangu, Kjetil Søreide, Salomone Di Saverio et al. · The Lancet Sep 2015 1,321
21 Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer David Samuel Alberts, P. Y. Liu, Edward V. Hannigan et al. · New England Journal of Medicine Open access 26 Dec 1996 1,244
22 Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan Alan N. Gordon, John Fleagle, David L. Guthrie et al. · Journal of Clinical Oncology 15 Jul 2001 1,242
23 An analysis of 8305 cases of carcinoid tumors Irvin Mark Modlin, András Sándor · Cancer 27 Sep 2000 1,208
24 Peritoneal carcinomatosis from non-gynecologic malignancies Babak Sadeghi, Catherine Arvieux, Olivier Gléhen et al. · Cancer 15 Jan 2000 1,203
25 Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure James S. Tomlinson, William R. Jarnagin, Ronald P. DeMatteo et al. · Journal of Clinical Oncology Open access 9 Oct 2007 1,190
26 Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study Olivier Gléhen, Fabrice Kwiatkowski, Paul Hendrick Sugarbaker et al. · Journal of Clinical Oncology 14 Aug 2004 1,189
27 A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer Andreas du Bois · JNCI Journal of the National Cancer Institute 2 Sep 2003 1,136
28 Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Jonathan A. Ledermann, F. Raja, Christina Fotopoulou et al. · Annals of Oncology Open access 27 Sep 2013 1,126
29 Carcinoid TumorsAn analysis of 2837 cases J. David Godwin · Cancer Aug 1975 1,108
30 Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases Timothy Michael Pawlik, Charles Raben Scoggins, Daria Zorzi et al. · Annals of Surgery Open access 19 Apr 2005 1,107
31 Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. Marshall S. Flam, Michelle E. St. John, Thomas F. Pajak et al. · Journal of Clinical Oncology Sep 1996 1,093
32 Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group Maurie M. Markman, Brian N. Bundy, David Samuel Alberts et al. · Journal of Clinical Oncology 15 Feb 2001 1,092
33 Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Terence C. Chua et al. · Journal of Clinical Oncology Open access 21 May 2012 1,075
34 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer Victor J. Verwaal, Sjoerd C. Bruin, Henk Boot et al. · Annals of Surgical Oncology 2 Jun 2008 1,039
35 Laparoscopic versus open surgery for suspected appendicitis Thomas Jaschinski, Christoph G Mosch, Michaela Eikermann et al. · Cochrane Database of Systematic Reviews Open access 28 Nov 2018 1,022
36 Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions Tito Livraghi, Shraga Nahum Goldberg, Sergio Lazzaroni et al. · Radiology Mar 2000 1,016
37 Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group Dirk Timmerman, Lil Valentin, Tom Bourne et al. · Ultrasound in Obstetrics and Gynecology Oct 2000 1,006
38 Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study Dominique M. Elias, François Noël Gilly, Florent Boutitie et al. · Journal of Clinical Oncology 16 Nov 2009 1,004
39 A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Ian J. Jacobs, D Oram, J. Fairbanks et al. · BJOG An International Journal of Obstetrics & Gynaecology Oct 1990 971
40 Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer Nancy E. Kemeny, Ying Huang, Alfred M. Cohen et al. · New England Journal of Medicine Open access 30 Dec 1999 965
41 Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy Henry Bismuth, René Adam, Francis Albert Lévi et al. · Annals of Surgery Open access Oct 1996 964
42 Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial Christophe Louvet, Roberto Labianca, Pascal R. Hammel et al. · Journal of Clinical Oncology Open access 20 May 2005 958
43 Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial Jacoba van der Zee, Dionisio González, Gerard C. van Rhoon et al. · The Lancet Apr 2000 946
44 Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study Robert Allen Burger, Michael W. Sill, Bradley J. Monk et al. · Journal of Clinical Oncology Open access 16 Nov 2007 883
45 A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Richard G. Moore, Donald Scott McMeekin, Amy Brown et al. · Gynecologic Oncology Open access 14 Oct 2008 882
46 Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial Amit M. Oza et al. · The Lancet Oncology Open access 24 Jun 2015 875
47 Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin Dominique M. Elias, Jérémie H. Lefèvre, Julie Chevalier et al. · Journal of Clinical Oncology 22 Dec 2008 874
48 Current Status of Gastrointestinal Carcinoids Irvin Mark Modlin, Mark S. Kidd, Igor Latich et al. · Gastroenterology Open access May 2005 852
49 Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial Valérie Vilgrain et al. · The Lancet Oncology 140 authors 26 Oct 2017 841
50 Peritoneal carcinomatosis from colorectal cancer David George Jayne, Stephanie Fook, Carol TT Loi et al. · British journal of surgery Dec 2002 834

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.